G Marcucci
Overview
Explore the profile of G Marcucci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1569
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marcucci G, Sanchis R, Ciarapica F, Bevilacqua M
IFAC Pap OnLine
. 2024 Apr;
55(10):1858-1863.
PMID: 38620859
The COVID-19 pandemic has had and is having devastating effects on the health of the population, but also on the economic health of companies and their supply chains. The old...
2.
Marcucci G, Beccuti G, Carosi G, Cetani F, Cianferotti L, Colao A, et al.
J Endocrinol Invest
. 2022 Apr;
45(9):1653-1662.
PMID: 35460461
Purpose: The main purpose of this study was to investigate the effects of 12 months of rhPTH (1-84) (Natpar) treatment in a cohort of patients selected according to the indications...
3.
Masi L, Marini F, Franceschelli F, Leoncini G, Cianferotti L, Cioppi F, et al.
Osteoporos Int
. 2021 Jun;
32(12):2461-2472.
PMID: 34097127
Introduction: Alkaline phosphatases (ALPs) are membrane-bound enzymes that hydrolyze monophosphate esters at a high pH (pH 8-10). Inorganic pyrophosphate, pyridoxal 5-phosphate, the activated form of vitamin B (PLP), and phosphoethanolamine...
4.
Pierangeli D, Marcucci G, Conti C
Phys Rev Lett
. 2019 Jul;
122(21):213902.
PMID: 31283311
Quantum and classical physics can be used for mathematical computations that are hard to tackle by conventional electronics. Very recently, optical Ising machines have been demonstrated for computing the minima...
5.
Marcucci G, Beltrami G, Tamburini A, Body J, Confavreux C, Hadji P, et al.
Ann Oncol
. 2019 May;
30(6):908-920.
PMID: 31111878
In the past decades, new cancer treatment approaches for children and adolescents have led to a decrease in recurrence rates and an increase in long-term survival. Recent studies have focused...
6.
Marcucci G, Masi L, Ferrari S, Haffner D, Javaid M, Kamenicky P, et al.
Osteoporos Int
. 2018 Jul;
29(11):2369-2387.
PMID: 30014155
A cause of hypophosphatemia is phosphate wasting disorders. Knowledge concerning mechanisms involved in phosphate wasting disorders has greatly increased in the last decade by the identification of phosphatonins, among them...
7.
Kumar B, Garcia M, Weng L, Jung X, Murakami J, Hu X, et al.
Leukemia
. 2017 Aug;
32(3):575-587.
PMID: 28816238
Little is known about how leukemia cells alter the bone marrow (BM) niche to facilitate their own growth and evade chemotherapy. Here, we provide evidence that acute myeloid leukemia (AML)...
8.
DAbundo L, Callegari E, Bresin A, Chillemi A, Elamin B, Guerriero P, et al.
Oncogene
. 2017 Aug;
36(47):6617-6626.
PMID: 28783166
Dysregulation of microRNAs (miRNAs) plays an important role in the pathogenesis of chronic lymphocytic leukemia (CLL). The Eμ-TCL1 transgenic mouse develops a form of leukemia that is similar to the...
9.
Blum W, Sanford B, Klisovic R, DeAngelo D, Uy G, Powell B, et al.
Leukemia
. 2016 Sep;
31(1):34-39.
PMID: 27624549
In this prospective phase 2 clinical trial conducted by Cancer and Leukemia Group B (CALGB, now the Alliance), we studied decitabine as maintenance therapy for younger adults with acute myeloid...
10.
Alachkar H, Fulton N, Sanford B, Malnassy G, Mutonga M, Larson R, et al.
Pharmacogenomics J
. 2016 Mar;
17(3):274-279.
PMID: 27019981
Asparaginase, which depletes asparagine and glutamine, activates amino-acid stress response. Oxidative stress mediated by excessive reactive oxygen species (ROS) causes enhanced mitochondrial permeabilization and subsequent cell apoptosis and is considered...